SECTOR ANALYSIS

Sleep Rare Disease Biotech Companies

Grades, scores, and FDA catalyst signals for Sleep Rare Disease stocks tracked by BiotechSign

← Full Screener FDA Calendar All Sectors

Companies

Avg Score

Top Grade

Grade A

Sleep Rare Disease Companies— 9 tracked

Ticker	Company	Score	Grade	Sector	Signals
AGIO	Agios Pharmaceuticals	81	A	Rare Disease	—
PHVS	Pharvaris NV	65	C	Rare Disease	—
PTCT	PTC Therapeutics	64	C	Rare Disease	—
INSM	Insmed Incorporated	60	C	Rare Disease	—
BCRX	BioCryst Pharmaceuticals	58	C	Rare Disease	—
RARE	Ultragenyx Pharmaceutical	57	C	Rare Disease	—
FOLD	Amicus Therapeutics	57	C	Rare Disease	—
BMRN	BioMarin Pharmaceutical	52	C	Rare Disease	—
PRQR	ProQR Therapeutics	44	D	Rare Disease	—

Not financial advice. All data and analysis provided by Guerilla Finance Inc. BiotechSign grades and scores are algorithmic signals only and do not constitute investment recommendations. Biotech investing involves significant risk, including the potential for complete loss of capital on binary FDA events. Always conduct your own due diligence before making investment decisions.